Zymergen Inc (ZY) USD0.001
Zymergen Inc. integrates computational and manufacturing technologies to design, engineer, and optimize microbes for industrial applications. The Company has developed a platform that treats the genome as a search space, utilizing machine learning algorithms and advanced automation to identify genetic changes. The Company's biofacturing platform, is a fusion of biology, chemistry and technology, is built on a stack that integrates techniques in molecular biology, chemistry, materials science, lab automation systems, software applications, databases and machine learning algorithms. Its biofacturing platform is designed to identify and create biomolecules and insert genes into a host microbe that produces the desired biomolecules. The Company serves to chemicals and materials, agriculture, and pharmaceuticals industries. The Company's product pipeline includes Electronics, Consumer Care, and Agriculture.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.